Results 11 to 20 of about 31,781 (199)
Medullary thyroid carcinoma [PDF]
Clinical Endocrinology, 2004 SummaryMedullary thyroid carcinoma (MTC) arises from parafollicular or C cells that produce calcitonin (CT), and accounts for 5–10% of all thyroid cancers. MTC is hereditary in about 25% of cases. The discovery of a MTC in a patient has several implications: disease extent should be evaluated, phaeochromocytoma and hyperparathyroidism should be ...
Sophie, Leboulleux +3 more
+7 more sources
Thyroid: Medullary carcinoma [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2013 Medullary thyroid cancers (MTC) are rare neuroendocrine tumors arising from the parafollicular C-cells of the thyroid. In this review, we provide a general overview of the classification, pathology, and clinical management of MTC. In the latter half, we survey the underlying genetic framework of MTC and its potential implications within a diagnostic ...
Somnay, Y, Schneider, D, Mazeh, H
openaire +3 more sources
Expert Review of Anticancer Therapy, 2023 Medullary thyroid carcinoma (MTC) constitutes approximately 5-10% of all thyroid cancers. Although the tumor forms in the thyroid, it doesn't originate from thyroid cells, but from the C cells or parafollicular cells which produce and release a hormone called calcitonin (CT). Starting from the second half of the 1900s, MTC was progressively studied and
Pelizzo, Maria Rosa +3 more
openaire +3 more sources
Clinical Case Reports, 2023 Key Clinical Message The occurrence of simultaneous multifocal papillary thyroid carcinoma and mixed medullary‐papillary carcinoma, as far as we know, has not been previously described.
Raquel Lalanda +5 more
doaj +1 more source
Histopathological study of thyroid carcinoma in Misan province [PDF]
Journal of Bioscience and Applied Research, 2022 Aims: "Thyroid carcinoma is specific malignant tumors derived from follicle cells including papillary and follicular carcinoma, and parafollicular, calcitonin-producing C-cells (medullary carcinoma)".This study aimed to provide a present outlook on ...
Osamah Wali, Abbas Mraisel, Alaa Salih
doaj +1 more source
The International Journal of Biological Markers, 2018 Aim: Due to the limits of calcitonin, other markers are warranted to better manage medullary thyroid carcinoma patients, and procalcitonin has been reported as promising.
Pierpaolo Trimboli +6 more
doaj +1 more source
Journal of Medical Case Reports, 2011 Introduction Papillary thyroid carcinoma and medullary thyroid carcinoma are two different thyroid neoplasia. The simultaneous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma as a collison tumor with metastases from both lesions
Sadat Alavi Mehr, Azarpira Negar
doaj +1 more source
Breast metastasis from medullary thyroid carcinoma: a report of a case
Surgical Case Reports, 2021 Background Metastasis to the breast is rare. We herein report a patient with metastatic medullary thyroid carcinoma to the breast for whom measuring the calcitonin level was an important clue to the correct diagnosis.
Yoko Omi +6 more
doaj +1 more source
Human Pathology Reports, 2022 Tumour-to-tumour metastasis is a rare incidence. Metastasis from colorectal cancer to primary thyroid neoplasm is extremely rare. We report a case of metastatic rectal adenocarcinoma to a medullary thyroid carcinoma.
Mahmoud Elsayed +2 more
doaj +1 more source
American Journal of Otolaryngology, 1993 Medullary thyroid carcinoma (MTC) comprises approximately 1–2% of thyroid malignancies and occurs in sporadic and heritable forms. Hereditary forms include multiple endocrine neoplasia (MEN) type 2A, familial medullary thyroid carcinoma (FMTC), and MEN type 2B.
Y L, Colson, S E, Carty
openaire +4 more sources